Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.

MLA

Lavoro, Alessandro, et al. “Identification of SLC22A17 DNA Methylation Hotspot as a Potential Biomarker in Cutaneous Melanoma.” Journal of Translational Medicine, vol. 22, no. 1, Oct. 2024, p. 887. EBSCOhost, https://doi.org/10.1186/s12967-024-05622-9.

APA

Lavoro, A., Falzone, L., Gattuso, G., Conti, G. N., Caltabiano, R., Madonna, G., Capone, M., McCubrey, J. A., Ascierto, P. A., Libra, M., & Candido, S. (2024). Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma. Journal of Translational Medicine, 22(1), 887. https://doi.org/10.1186/s12967-024-05622-9

Chicago

Lavoro, Alessandro, Luca Falzone, Giuseppe Gattuso, Giuseppe N Conti, Rosario Caltabiano, Gabriele Madonna, Mariaelena Capone, et al. 2024. “Identification of SLC22A17 DNA Methylation Hotspot as a Potential Biomarker in Cutaneous Melanoma.” Journal of Translational Medicine 22 (1): 887. doi:10.1186/s12967-024-05622-9.